Skip to main content

AKAVA Therapeutics

Founded: 2019

Northwestern Inventor:
Richard Silverman
Weinberg College of Arts and Sciences
Department of Chemistry and Department of Molecular Biosciences

Feinberg School of Medicine
Department of Pharmacology

AKAVA Therapeutics is developing first-in-class small molecule therapeutics that inhibit enzymes, inhibit cancer, and inhibit protein aggregation for a variety of cancers and neurodegenerative diseases.